Form D · Biotechnology
Cell Source, Inc.
New York, NY · CIK 0001569340
Offering snapshot reported Oct 6, 2023 · SEC filing
- Reported sold
- $3.91M Indefinite offering
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 6, 2023 | Initial | $3,905,134 | No comparison | 48 | SEC filing |
| Oct 18, 2019 | Initial | $8,880,234 | No comparison | 62 | SEC filing |
| Nov 13, 2015 | Initial | $252,500 | No comparison | 5 | SEC filing |
| Jul 28, 2015 | Initial | $145,000 | No comparison | 3 | SEC filing |
| Jun 3, 2015 | Initial | $750,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-494016
Source: Form D, filed Oct 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis Brown | Director |
| Yoram Drucker | Director |
| Ben Friedman | Director |
| Itamar Shimrat | Executive |
| Darlene Soave | Director |
| George Verstraete | Director |
| David Zolty | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
57 West 57 Th Street, Suite 400
New York, NY, 10019
New York, NY, 10019